483 related articles for article (PubMed ID: 31281535)
1. Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression.
Shi L; Sheng J; Wang M; Luo H; Zhu J; Zhang B; Liu Z; Yang X
Theranostics; 2019; 9(14):4115-4129. PubMed ID: 31281535
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
3. Oral probiotics microgel plus Galunisertib reduced TGF-β blockade resistance and enhanced anti-tumor immune responses in colorectal cancer.
Niu L; Liu Y; Li N; Wang Y; Kang L; Su X; Xu C; Sun Z; Sang W; Xu J; Guo H; Shen S
Int J Pharm; 2024 Mar; 652():123810. PubMed ID: 38244648
[TBL] [Abstract][Full Text] [Related]
4. Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance.
Shi L; Sheng J; Chen G; Zhu P; Shi C; Li B; Park C; Wang J; Zhang B; Liu Z; Yang X
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028692
[TBL] [Abstract][Full Text] [Related]
5. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
6. Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice.
Tang H; Zhou T; Jin W; Zong S; Mamtimin T; Salama ES; Jeon BH; Liu P; Han H; Li X
Life Sci; 2023 Jul; 324():121709. PubMed ID: 37100380
[TBL] [Abstract][Full Text] [Related]
7. The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antitumor immune cells.
Rana M; Kansal R; Chaib M; Teng B; Morrrison M; Hayes DN; Stanfill AG; Shibata D; Carson JA; Makowski L; Glazer ES
Mol Carcinog; 2022 Jun; 61(6):549-557. PubMed ID: 35319799
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
[TBL] [Abstract][Full Text] [Related]
9. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice.
Ding G; Gong Q; Ma J; Liu X; Wang Y; Cheng X
Cancer Sci; 2021 Oct; 112(10):4050-4063. PubMed ID: 34289209
[TBL] [Abstract][Full Text] [Related]
12. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.
Sivan A; Corrales L; Hubert N; Williams JB; Aquino-Michaels K; Earley ZM; Benyamin FW; Lei YM; Jabri B; Alegre ML; Chang EB; Gajewski TF
Science; 2015 Nov; 350(6264):1084-9. PubMed ID: 26541606
[TBL] [Abstract][Full Text] [Related]
13. [Probiotics enhance the efficacy of fecal microbiota transplantation in severe acute liver injury].
Fan LD; Liu YM; Cheng ML
Zhonghua Gan Zang Bing Za Zhi; 2020 Apr; 28(4):345-350. PubMed ID: 32403888
[No Abstract] [Full Text] [Related]
14. Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites.
Gao G; Shen S; Zhang T; Zhang J; Huang S; Sun Z; Zhang H
EBioMedicine; 2023 May; 91():104533. PubMed ID: 37027929
[TBL] [Abstract][Full Text] [Related]
15. Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade.
Holmgaard RB; Schaer DA; Li Y; Castaneda SP; Murphy MY; Xu X; Inigo I; Dobkin J; Manro JR; Iversen PW; Surguladze D; Hall GE; Novosiadly RD; Benhadji KA; Plowman GD; Kalos M; Driscoll KE
J Immunother Cancer; 2018 Jun; 6(1):47. PubMed ID: 29866156
[TBL] [Abstract][Full Text] [Related]
16. Tumor Colonization and Therapy by
Gentschev I; Petrov I; Ye M; Kafuri Cifuentes L; Toews R; Cecil A; Oelschaeger TA; Szalay AA
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551519
[TBL] [Abstract][Full Text] [Related]
17. [Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].
Xia P; Zhu J; Zhu G
Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):538-44. PubMed ID: 24028055
[TBL] [Abstract][Full Text] [Related]
18. Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
Huang HC; Vlasova AN; Kumar A; Kandasamy S; Fischer DD; Deblais L; Paim FC; Langel SN; Alhamo MA; Rauf A; Shao L; Saif LJ; Rajashekara G
Benef Microbes; 2018 Jan; 9(1):71-86. PubMed ID: 29022385
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
20.
Zhang SL; Han B; Mao YQ; Zhang ZY; Li ZM; Kong CY; Wu Y; Chen GQ; Wang LS
Gut Microbes; 2022; 14(1):2046246. PubMed ID: 35259052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
